Expert opinion regarding clinical and other outcome considerations in the formulary review of immune globulin.
Sorensen
Ricardo
R
Department of Pediatrics, Louisiana State University Health Sciences Center, Children's Hospital New Orleans, LA 70118, USA. rsoren@lsuhsc.edu
D002626:Chemistry, Pharmaceutical; D004334:Drug Administration Schedule; D016527:Drug Costs; D017723:Drug Utilization Review / Q000592:standards*; D005569:Formularies as Topic; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects / Q000191:economics / Q000592:standards / Q000627:therapeutic use; D007155:Immunologic Factors / Q000009:adverse effects / Q000191:economics / Q000592:standards / Q000627:therapeutic use; D017063:Outcome Assessment, Health Care; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D016896:Treatment Outcome
D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors